China
China social e-commerce player Red raises $300m
Alibaba Group has led a $300 million Series D round of funding for Red, a social e-commerce site that enables Chinese consumers to buy products from overseas.
Lone Star to buy Australia-listed Sino Gas for $402m
Sino Gas & Energy Holdings, an Australia-listed natural gas developer focused on China, has accepted a A$530 million ($402 million) buyout offer from Lone Star Funds.
Fund focus: AlphaX tracks evolving China VC story
Having raised $270 million for his debut fund at AlphaX Partners, former Highland Capital Partners executive Chuan Thor is keen to tap emerging trends in consumer internet and enterprise services
China's Genesis targets $600m for second fund
Genesis Capital, a Chinese venture capital firm established by Richard Peng, formerly head of M&A at Tencent Holdings, is targeting $600 million for its second fund.
China's SenseTime closes $620m Series C-plus round
Chinese artificial intelligence (AI) technology developer SenseTime has raised $620 million in Series C-plus funding, its second capital injection in as many months. The investment values the business at over $4.5 billion.
Hony sells Chinese hospital to Hong Kong-listed platform
Hony Capital has agreed to sell three private hospitals in Zhejiang province to Hospital Corporation of China (HCC), a Hong Kong-listed platform it established several years ago, for RMB630 million ($98 million).
Wine in China: Nurturing the vine
Private equity interest in wine is set to increase as its role in the China luxury goods thesis comes further into focus. Culture, character, and copycatting will be at the top of investors’ strategic agenda
China used car trading business Uxin files for US IPO
Uxin Group, a Chinese e-commerce platform that specializes in used-car trading and related services, has filed for a US IPO. Jeneration Capital, Warburg Pincus, and Tiger Global Management are among the company’s PE backers.
CITIC Capital invests China-Europe logistics providers
CITIC Capital has backed two China-Europe logistics providers in separate deals of undisclosed size. The GP is investing via its Silk Road Fund, which targets geographies in China’s One Belt One Road (OBOR) agenda.
Deal focus: VCs back Ezbuy’s cross-border e-commerce
A group of VCs including China’s Sky9 Capital are backing a global push by Southeast Asian e-commerce operator Ezbuy. The plan will require combining international vision with local knowhow
Q&A: Ofo's Alan Jiang
Alan Jiang helped launch Uber in China, Malaysia and Vietnam before serving as Indonesia country head. Now he is leading Chinese bike-sharing start-up Ofo’s expansion in Southeast Asia
Chinese state-backed PE fund anchors Foxconn IPO
A private equity fund backed by China’s State Development & Investment Corporation (SDIC) is the largest strategic investor in the RMB27.1 billion ($4.3 billion) Shanghai IPO of a Foxconn Technology Group manufacturing unit.
CDH leads round for Chinese DNA-based drug developer
CDH Investments has led a RMB250 million ($39 million) Series B round of funding for HitGen, a Chinese biotech company that develops drugs based on the synthesis and screening of DNA fragments.
VIDEO: Shoreline Capital's Tony Liu
Tony Liu, COO of Shoreline Capital, discusses investment opportunities in China's non-performing loan (NPL) space.
China's Sinovation launches AI-focused fund
Sinovation Ventures has formed a RMB2.5 billion ($395 million) venture capital fund that will focus on artificial intelligence (AI). It is a cooperative effort with the Guangzhou government to drive technology development.
Pivotal raises $150m for China life sciences fund
Pivotal Bioventure Partners China, an investment platform of Hong Kong conglomerate Nan Fung Group, has raised $150 million for a fund that will incubate Chinese life science start-ups.
China VC player Banyan changes name to Gaorong
Chinese venture capital firm Banyan Capital has changed its English name to Gaorong Capital. The aim is to achieve more consistent brand recognition because Gaorong is how the group’s Chinese name is pronounced.
Primavera reaches $1.5b first close on China fund
Primavera Capital Group has completed a first close of approximately $1.5 billion on its third China fund. The overall target is $2.8 billion.
Brii Biosciences gets $260m for China expansion
A group of VCs, including Sequoia Capital, have committed $260 million to Brii Biosciences, a China and US-based healthcare start-up executing a number of China-focused growth initiatives.
China early-stage investment round-up
Venture capital deals involving FoxConn, China Minsheng Investment Group, Qiming Venture Partners, GGV Capital, Matrix Partners China, Hongxiu VC, Geekbeans Capital, Albatross Venture, Node Capital, and Insight Capital
Fund focus: Tapping the Alibaba talent seam
Vision Plus Capital looks to tap the entrepreneurial talent developing in Alibaba Group's ecosystem for its second US dollar and renminbi-denominated funds
Chinese VCs join $300m round for US, Hong Kong-based Grail
Ally Bridge Group, Hillhouse Capital and 6 Dimensions Capital have co-led a $300 million Series C round for Grail, a biotechnology development firm based in Hong Kong and the US.
Australia's Santos rejects EIG buyout offer
Australia-listed oil and gas supplier Santos has rejected a buyout offer from EIG Global Energy Partners backed by China-based private equity firm Hony Capital and gas distributor ENN Group. The deal would have valued the company at up to $10.9 billion.
CDH, DCP to invest $70m in China's Sunpower
DCP Capital Partners, a private equity firm established by the former China heads of KKR, has agreed to jointly invest $70 million alongside CDH Investments in Chinese energy industry supplier Sunpower.